Galvanize Therapeutics
PrivateLast Round
Series C
Sep 3, 2025
Total Funding Raised
$218M
Company Overview
Galvanize Therapeutics is a medical technology company that develops energy-based devices utilizing high-voltage electrical pulses to enhance biological processes for improved patient care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galvanize Therapeutics Comparables
Compare Galvanize Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Surgnova Healthcare Technologies | 80% | |
| AngioDynamics, Inc. | 79% | |
| HistoSonics | 78% |
Galvanize Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 3, 2025 | ||||
| Series B | Sep 15, 2022 | ||||
| Series A | Mar 16, 2021 |
Key People
Founding team and executive leadership
Galvanize Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series C |
| Perceptive Advisors | Series C |
| Ally Bridge Group | Series C |
| Gilmartin Capital | Series B, Series C |
| Longaeva | Series C |
| Fidelity Management & Research Company | Series C, Series B |
| Apple Tree Partners | Series B, Series C, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Senior PM hire signals market development for Aliya PEF platform.
- Sep 3, 2025
$100M round raised.
Galvanize Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Galvanize Therapeutics's valuation, stock price, and market status.
Is Galvanize a public or private company?
Galvanize is a private company.
What is the current stock price of Galvanize?
Galvanize is a private company with no public stock price. No recent secondary market data is available.
How much is Galvanize worth (valuation)?
Valuation information for Galvanize is not publicly available.
Can I buy Galvanize stock?
Galvanize shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Galvanize's last funding round?
Galvanize's most recent funding round was Series C on September 3, 2025.
Who are the main investors in Galvanize?
Key investors in Galvanize include Fidelity Management & Research Company, Apple Tree Partners, Sofinnova Partners.
Will Galvanize IPO soon?
No public IPO plans have been announced for Galvanize.
How can I track Galvanize secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Galvanize's secondary market activity and sign up for updates.